Dr. Leonard Freedman is the Chief Science Office of the Frederick National Laboratory for Cancer Research. He has held leadership positions in basic biomedical research, drug discovery, and science policy in both the private and non-profit sectors, as well as in academia. In 2012, Dr. Freedman became the founding President of the Global Biological Standards Institute (GBSI). Prior to starting GBSI, Dr. Freedman served as Vice Dean for Research and Professor of Biochemistry and Molecular Biology at Jefferson Medical College, Thomas Jefferson University. Dr. Freedman also led discovery research efforts in the pharmaceutical industry as a Vice President at Wyeth and Executive Director at Merck. Before moving to industry, Dr. Freedman was a Member and Professor of Cell Biology & Genetics at Memorial Sloan-Kettering Cancer Center and Weil Cornell Medical College. There, Dr. Freedman and his lab made several highly impactful discoveries in the area of nuclear hormone receptor structure and function. Dr. Freedman has received numerous competitively funded grants, and has been the recipient of several research honors, including the Boyer Award for Biomedical Research, and a MERIT award from the National Institutes of Health. He was also the 2002 recipient of the Ernst Oppenheimer Award from The Endocrine Society. Dr. Freedman has published extensively and served on numerous scientific review panels and editorial boards. He was an editor of the journal Molecular and Cellular Biology for ten years. In addition, Dr. Freedman has served on the Board of Directors of the American Type Culture Collection (ATCC).